DailySand LogoDailySand
BlogSearchArchiveTimelineAbout
Today's DigestBlogArchiveTimelineTopicsSearchAboutFAQContact

Content

  • Today's Digest
  • Archive
  • Blog
  • Timeline
  • Topics
  • Search

Tools

  • MCP Server
  • JSON API
  • OpenAPI Spec
  • RSS Feed
  • Sitemap

Company

  • About
  • FAQ
  • Contact

Legal

  • Privacy Policy
  • Terms of Service
  • AI Context (llms.txt)
  • AI Directives
© 2026 DailySand. Not investment advice.Daily AI, Investing & Critical Minerals Intelligence
← All Topics

Bristol Myers Squibb

1 item across 1 digest

Related Daily Digests

How Anthropic's $900 Billion Valuation Rewrote the AI Investment Playbook

May 15, 2026

All Items

FinancialCNBC Tech

Bristol Myers Squibb turns to China to develop new drugs in newest cross-continent collaboration

Bristol Myers Squibb has formed a partnership with a Chinese company for drug development in a new cross-continent collaboration model. This represents a shift in pharmaceutical industry partnerships toward leveraging China's capabilities for drug development despite ongoing geopolitical tensions.

#Bristol Myers Squibb#China#pharmaceutical
Read original →